For the readers interested in the stock health of Femasys Inc. (FEMY). It is currently valued at $8.02. When the transactions were called off in the previous session, Stock hit the highs of $9.49, after setting-off with the price of $7.16. Company’s stock value dipped to $7.0172 during the trading on the day. When the trading was stopped its value was $6.99.
Recently in News on July 20, 2021, Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed. First in Class Insemination Treatment for Infertility. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Femasys Inc. shares are logging -41.67% during the 52-week period from high price, and 18.46% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.77 and $13.75.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1053553 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Femasys Inc. (FEMY) recorded performance in the market was -33.17%. At the time of this writing, the total market value of the company is set at 91.99M, as it employees total of 24 workers.
Market experts do have their say about Femasys Inc. (FEMY)
During the last month, 0 analysts gave the Femasys Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
Technical breakdown of Femasys Inc. (FEMY)
In the last 20 days, the company’s Stochastic %K was 13.30% and its Stochastic %D was recorded 25.37%.
Bearing in mind the latest performance of Femasys Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -33.17%. The shares increased approximately by -5.65% in the 7-day charts and went up by -33.17% in the period of the last 30 days.